secwatch.observer — SEC 8-K summary
======================================

Issuer:     QHSLab, Inc. (USAQ)
CIK:        0000856984
Form:       8-K
Filed at:   2024-09-25T23:59:59+00:00
Accession:  0001493152-24-038060
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QHSLab secures $297K grant from global consumer health firm for allergic rhinitis digital study
--------------------------------------------------------------------------------

- QHSLab received $297,360 grant from a Global Leader in Consumer Health to advance digital medicine for allergic rhinitis.
- Study registered as NCT06603935 on ClinicalTrials.gov; titled 'Harnessing Digital Medicine Tools...'
- Research will evaluate QHSLab's AME and ARIS digital tools for primary care allergy management.
- Principal Investigator: Marcos Sanchez-Gonzalez, MD, PhD; study aims to improve patient outcomes and reduce costs.
- Grant reflects shared commitment to digital health innovation and evidence-based self-care for patients.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856984/000149315224038060/0001493152-24-038060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856984/000149315224038060/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-038060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer